A Systematic Review and Meta-Analysis of Efficacy and Safety of Liraglutide in Patients with Type 2 Diabetes Mellitus.

Diabetes Metab Syndr Obes · 2026 · PMC12982893 · PMID 41836360

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Additionally, there was a comparable reduction with sulfonylureas (–2.27 kg [95% CI: –4.88, 0.35]; p = 0.09) and SGLT2 inhibitors (–0.19 kg [95% CI: –0.51, 0.13]; p = 0.24) did not reach statistical significance ( Figure 3D ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.